ATE157541T1 - Pge1 und derivate für mukosale oder dermale anwendung - Google Patents
Pge1 und derivate für mukosale oder dermale anwendungInfo
- Publication number
- ATE157541T1 ATE157541T1 AT90105854T AT90105854T ATE157541T1 AT E157541 T1 ATE157541 T1 AT E157541T1 AT 90105854 T AT90105854 T AT 90105854T AT 90105854 T AT90105854 T AT 90105854T AT E157541 T1 ATE157541 T1 AT E157541T1
- Authority
- AT
- Austria
- Prior art keywords
- gamma
- derivatives
- linolenic acid
- mucosal
- pge1
- Prior art date
Links
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000711 alprostadil Drugs 0.000 title abstract 2
- 230000002500 effect on skin Effects 0.000 title abstract 2
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 title abstract 2
- 229930186217 Glycolipid Natural products 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 150000003904 phospholipids Chemical class 0.000 abstract 2
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- IUKXMNDGTWTNTP-RHDCIPCHSA-N 15-HETrE Chemical compound CCCCCC(O)\C=C\C=C/C\C=C/CCCCCCC(O)=O IUKXMNDGTWTNTP-RHDCIPCHSA-N 0.000 abstract 1
- 206010003645 Atopy Diseases 0.000 abstract 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pediatric Medicine (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3910760A DE3910760A1 (de) | 1989-04-04 | 1989-04-04 | Neue verwendung bekannter substanzen sowie verfahren zur herstellung von geeigneten praeparaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE157541T1 true ATE157541T1 (de) | 1997-09-15 |
Family
ID=6377750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90105854T ATE157541T1 (de) | 1989-04-04 | 1990-03-28 | Pge1 und derivate für mukosale oder dermale anwendung |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0399175B1 (enExample) |
| AT (1) | ATE157541T1 (enExample) |
| DE (2) | DE3910760A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252602A (en) * | 1991-10-11 | 1993-10-12 | Rafeul Alam | Effects of misoprostol on allergic responses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4009282A (en) * | 1973-12-17 | 1977-02-22 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with prostaglandins |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| DE69025787T2 (de) * | 1989-04-04 | 1996-10-31 | Beiersdorf Ag | Mittel zur Atopieprophylaxe |
-
1989
- 1989-04-04 DE DE3910760A patent/DE3910760A1/de active Granted
-
1990
- 1990-03-28 EP EP90105854A patent/EP0399175B1/en not_active Expired - Lifetime
- 1990-03-28 AT AT90105854T patent/ATE157541T1/de not_active IP Right Cessation
- 1990-03-28 DE DE69031360T patent/DE69031360T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69031360T2 (de) | 1998-04-02 |
| DE3910760A1 (de) | 1990-10-11 |
| DE69031360D1 (de) | 1997-10-09 |
| DE3910760C2 (enExample) | 1992-01-02 |
| EP0399175B1 (en) | 1997-09-03 |
| EP0399175A2 (en) | 1990-11-28 |
| EP0399175A3 (en) | 1992-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2110060T3 (es) | Uso de acidos grasos para aumentar la absorcion intestinal del calcio. | |
| DK0502502T3 (da) | Topisk præparat indeholdende ketoprofenlysinat | |
| BR9407250A (pt) | Uso de uma droga tendo atividade vasodilatadora para a fabricação de um medicamento para administração transmucosal transdérmica intranasal e retal | |
| BR8803709A (pt) | Umectante para uma composicao de tratamento de pele e a respectiva composicao | |
| ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
| EG19912A (en) | The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders | |
| CA2120367A1 (en) | Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology | |
| ES2084579T3 (es) | Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol. | |
| ES2061989T3 (es) | Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis. | |
| ATE143261T1 (de) | Zusammensetzung zur behandlung entzündlicher darmerkrankungen | |
| IT1235153B (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
| DE69029625D1 (de) | Verwendung von Retinoiden zur Umkehr glucocorticoid-induzierter Hautatrophie | |
| KR910005858A (ko) | 지방산 요법 | |
| ES555118A0 (es) | Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas. | |
| ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
| DE69031360D1 (de) | PGE1 und Derivate für mukosale oder dermale Anwendung | |
| MX9304185A (es) | Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina. | |
| NO921223L (no) | Kombinasjonspreparat med antitrombotisk virkning | |
| AU569840B2 (en) | Use of oleanolic acid for ulcer treatment | |
| ES535091A0 (es) | Procedimiento de obtencion de una fraccion de hidrocarburos a partir de cera de abeja. | |
| ES2084348T3 (es) | N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares. | |
| ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. | |
| ES2010181B3 (es) | Procedimiento para la obtencion de un medicamento. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |